期刊文献+

以VEGF受体为靶向的融合毒素的研究 被引量:1

下载PDF
导出
摘要 肿瘤的快速生长主要依赖于新生血管的形成。血管内皮生长因子(VEGF)在刺激血管内皮细胞生长和诱导血管生成方面起重要作用。肿瘤组织因血管含量丰富,VEGF特异性受体的数目远高于邻近正常组织,因此可以将血管内皮生长因子和某些细胞毒素构建为融合毒素,特异性定位于肿瘤部位,通过抑制血管的增生达到抑制肿瘤的目的。国外自二十世纪九十年代后期开展这方面研究,国内尚少见此类报道。本文就此类融合毒素的设计及临床研究等方面的进展作一综述。
出处 《中国生物制品学杂志》 CAS CSCD 2004年第3期187-189,共3页 Chinese Journal of Biologicals
  • 相关文献

参考文献12

  • 1Hotz HG, Gill PS, Masood R, et al. Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion prtein reduces angiogenesis and growth of pancreatic cancer. J Gastrointes Surg,2002,6(2): 159-166.
  • 2Brown L F, Berse B, Jackman R W, et al. Expression of vascular permeability factor(vascular endothelial growth factor)and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res, 1993,53: 4727-4735.
  • 3Ramakrisnan S,Olson TA,Bautch VL,et al. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-I -positiive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res, 1996,56(6): 1324-1330.
  • 4Folkman J. The role of Cangiogenesis in tumor growth. Cancer Biol, 1992,365-371.
  • 5Hoffmann S,Masood R,Zhang Y,et al. Selective Killing of PRE with a vascular endothelial growth factor chimeric toxin.Invest Ophthalmol Vis Sci ,2000,41 (8) :2389-2389.
  • 6Wild R, Dhanabal M, Olson TA, et al. Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells. Br J cancer,2000,83(8): 1077-1083.
  • 7Denekamp J. Endothelial cell proliferation as a novel approach to target ing tumour therapy. J Cancer, 1982,45:136-139.
  • 8Plate KH, Breier G, et al. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogen esis. Cancer Res, 1993,53:5822-5827.
  • 9Ferrara N, Henzel W. Pituitary follicular cells secrete a novel heparinbinding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun, 1998,161: 851-855.
  • 10Tischer E. The human gene for vascular endothelial growth factor: multiple protein froms are endcoded thrugh alternative exon splicing. J Biol Chem, 1991,266:11947-11954.

同被引文献8

  • 1Carmeliet P. Angiogenesis in life, disease and medicine. Nature, 2005, 438(7070) :932-936.
  • 2Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res, 2006, 312(5) :549-560.
  • 3Petersen I. Antiangiogenesis,anti-VEGF(R) and outlook. Recent Results Cancer Res, 2007,176(11) : 189-199.
  • 4Manning EA, Ullman JG, Leatherman JM, et al. A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an inenune-based mechanism. Clin Cancer Res, 2007,13 (13) : 3951-3959.
  • 5Weigand M, Hantd P, Kreienberg R, et al. Autocfine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro. Angiogenesis, 2005,8 (3) : 197- 204.
  • 6Fuh G, Li B, Crowley C, et al. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem, 1998,273(18) : 11197-11204.
  • 7Lu D, Kussie P,Pytowski B,et al. Identification of the residues in the extracelhlar region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies. J Biol Chem, 2000, 275(19) : 14321-14330.
  • 8Xia G, Kumar SR, Hawes D, et al. Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol,2006,175 (4) : 1245-1252.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部